| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| apr-246 | cellular tumor antigen p53 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Esophageal Neoplasms[MeSHID:D004938] Stomach[MeSHID:D013270] Malignant neoplasm of urinary bladder[MeSHID:D001749] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Adenocarcinoma[MeSHID:D000230] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of ovary[MeSHID:D010051] |
1.18 | phase 2 | unknown |
| click here to return to the previous page | ||||||||